---
layout: splash
title: 네이처셀 (007390)
excerpt: 네이처셀의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
keywords: 네이처셀, 007390
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 7,060 | <span style="color: cornflowerblue">-1.8<small>%</small></span> | Q:제약 | - | 7.7 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 기초 의약물질 및 생물학적 제제 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 닥터쥬크르 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 1992년 11월 30일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 김주선, 변대중(각자대표) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.naturecell.co.kr](http://www.naturecell.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 03&#x2011;11 | | [주주총회소집공고](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240311000622){:target="_blank"} |
|  | | [의결권대리행사권유참고서류](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240311000604){:target="_blank"} |
|  | | [주주총회집중일개최사유신고              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240311900708){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![007390](/stock/images/007390.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 7,060 | <span style="color: cornflowerblue">-1.8<small>%</small></span> | <span style="color: tomato">1.3<small>%</small></span> | <span style="color: cornflowerblue">-5.2<small>%</small></span> | <span style="color: cornflowerblue">-10.3<small>%</small></span> | <span style="color: cornflowerblue">-12.7<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-56.9<small>%</small></span> | 72.1<small>%</small> | -0.79 | -71.8<small>%</small> | -61.5<small>%</small> | 0.8 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | - | 7.7 | - | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/007390/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=007390){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A007390&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=007390){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/007390){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/007390/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![007390](/stock/images/007390_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -56.9<small>%</small> | 72.1<small>%</small> | -0.79 | -71.8<small>%</small> | -61.5<small>%</small> |
| 적립식[^fn_tech_metric_dca] | -16.4<small>%</small> | 70.0<small>%</small> | -0.23 | -55.6<small>%</small> | -41.5<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -58.1<small>%</small> | 67.2<small>%</small> | -0.87 | -74.5<small>%</small> | -62.3<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -43.3<small>%</small> | 45.3<small>%</small> | -0.95 | -57.2<small>%</small> | -44.9<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -54.0<small>%</small> | 52.9<small>%</small> | -1.02 | -62.0<small>%</small> | -53.1<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -44.4<small>%</small> | 53.8<small>%</small> | -0.83 | -63.1<small>%</small> | -50.7<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -48.3<small>%</small> | 48.4<small>%</small> | -1.00 | -60.4<small>%</small> | -49.3<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -3.9<small>%</small> | 35.5<small>%</small> | -0.11 | -29.8<small>%</small> | -27.5<small>%</small> |
| MACD[^fn_tech_metric_macd] | -68.3<small>%</small> | 60.2<small>%</small> | -1.14 | -74.7<small>%</small> | -62.4<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![007390](/stock/images/007390_corr.png){: .align-center}

|       | [제넥신](/095700/) | [두산퓨얼셀](/336260/) | [카카오게임즈](/293490/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [컴투스](/078340/) | [콜마비앤에이치](/200130/) | [한화솔루션](/009830/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![007390](/stock/images/007390_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}